2024

Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in Melanoma Care

ROTTERDAM, Netherlands and SAN DIEGO, Oct. 24, 2024 /PRNewswire/ — SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory, and infectious diseases, announced today the results of a comprehensive systematic review and meta-analysis conducted by Melanoma Institute of Australia (MIA).

Read More
MRV News
Melanoma News
Archive
Menu